Home > > > > > Report Detail

Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 12-Jul-2019
No. of pages: 97
Inquire Before Buying

Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems.

Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development.

In 2018, the global Multiple Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis development in United States, Europe and China.

The key players covered in this study

- Abbvie

- Acorda Therapeutics

- Bayer HealthCare

- Biogen

- Genzyme (Sanofi)

- GlaxoSmithKline

- Merck Serono

- Novartis

- Pfizer

- Teva

Market segment by Type, the product can be split into

- Injectable agents

- Oral agents

Market segment by Application, split into

- Hosptial

- Research

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players.

- To present the Multiple Sclerosis development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Sclerosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Injectable agents
1.4.3 Oral agents
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Market Share by Application (2014-2025)
1.5.2 Hosptial
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Sclerosis Market Size
2.2 Multiple Sclerosis Growth Trends by Regions
2.2.1 Multiple Sclerosis Market Size by Regions (2014-2025)
2.2.2 Multiple Sclerosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Multiple Sclerosis Market Size by Manufacturers
3.1.1 Global Multiple Sclerosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Sclerosis Key Players Head office and Area Served
3.3 Key Players Multiple Sclerosis Product/Solution/Service
3.4 Date of Enter into Multiple Sclerosis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Sclerosis Market Size by Type (2014-2019)
4.2 Global Multiple Sclerosis Market Size by Application (2014-2019)
5 United States
5.1 United States Multiple Sclerosis Market Size (2014-2019)
5.2 Multiple Sclerosis Key Players in United States
5.3 United States Multiple Sclerosis Market Size by Type
5.4 United States Multiple Sclerosis Market Size by Application
6 Europe
6.1 Europe Multiple Sclerosis Market Size (2014-2019)
6.2 Multiple Sclerosis Key Players in Europe
6.3 Europe Multiple Sclerosis Market Size by Type
6.4 Europe Multiple Sclerosis Market Size by Application
7 China
7.1 China Multiple Sclerosis Market Size (2014-2019)
7.2 Multiple Sclerosis Key Players in China
7.3 China Multiple Sclerosis Market Size by Type
7.4 China Multiple Sclerosis Market Size by Application
8 Japan
8.1 Japan Multiple Sclerosis Market Size (2014-2019)
8.2 Multiple Sclerosis Key Players in Japan
8.3 Japan Multiple Sclerosis Market Size by Type
8.4 Japan Multiple Sclerosis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Sclerosis Market Size (2014-2019)
9.2 Multiple Sclerosis Key Players in Southeast Asia
9.3 Southeast Asia Multiple Sclerosis Market Size by Type
9.4 Southeast Asia Multiple Sclerosis Market Size by Application
10 India
10.1 India Multiple Sclerosis Market Size (2014-2019)
10.2 Multiple Sclerosis Key Players in India
10.3 India Multiple Sclerosis Market Size by Type
10.4 India Multiple Sclerosis Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Sclerosis Market Size (2014-2019)
11.2 Multiple Sclerosis Key Players in Central & South America
11.3 Central & South America Multiple Sclerosis Market Size by Type
11.4 Central & South America Multiple Sclerosis Market Size by Application
12 International Players Profiles
12.1 Abbvie
12.1.1 Abbvie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Sclerosis Introduction
12.1.4 Abbvie Revenue in Multiple Sclerosis Business (2014-2019)
12.1.5 Abbvie Recent Development
12.2 Acorda Therapeutics
12.2.1 Acorda Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Sclerosis Introduction
12.2.4 Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)
12.2.5 Acorda Therapeutics Recent Development
12.3 Bayer HealthCare
12.3.1 Bayer HealthCare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Sclerosis Introduction
12.3.4 Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)
12.3.5 Bayer HealthCare Recent Development
12.4 Biogen
12.4.1 Biogen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Sclerosis Introduction
12.4.4 Biogen Revenue in Multiple Sclerosis Business (2014-2019)
12.4.5 Biogen Recent Development
12.5 Genzyme (Sanofi)
12.5.1 Genzyme (Sanofi) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Sclerosis Introduction
12.5.4 Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)
12.5.5 Genzyme (Sanofi) Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Sclerosis Introduction
12.6.4 GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Merck Serono
12.7.1 Merck Serono Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Sclerosis Introduction
12.7.4 Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)
12.7.5 Merck Serono Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Sclerosis Introduction
12.8.4 Novartis Revenue in Multiple Sclerosis Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Sclerosis Introduction
12.9.4 Pfizer Revenue in Multiple Sclerosis Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Teva
12.10.1 Teva Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Sclerosis Introduction
12.10.4 Teva Revenue in Multiple Sclerosis Business (2014-2019)
12.10.5 Teva Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Multiple Sclerosis Key Market Segments
Table Key Players Multiple Sclerosis Covered
Table Global Multiple Sclerosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Market Size Market Share by Type 2014-2025
Figure Injectable agents Figures
Table Key Players of Injectable agents
Figure Oral agents Figures
Table Key Players of Oral agents
Table Global Multiple Sclerosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hosptial Case Studies
Figure Research Case Studies
Figure Multiple Sclerosis Report Years Considered
Table Global Multiple Sclerosis Market Size 2014-2025 (Million US$)
Figure Global Multiple Sclerosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Sclerosis Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Sclerosis Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Market Share by Regions 2014-2019
Figure Global Multiple Sclerosis Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Sclerosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Share by Manufacturers (2014-2019)
Figure Global Multiple Sclerosis Market Share by Manufacturers in 2018
Table Global Multiple Sclerosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Sclerosis Product/Solution/Service
Table Date of Enter into Multiple Sclerosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Size Share by Type (2014-2019)
Figure Global Multiple Sclerosis Market Size Market Share by Type (2014-2019)
Table Global Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Sclerosis Market Size Share by Application (2014-2019)
Figure Global Multiple Sclerosis Market Size Market Share by Application (2014-2019)
Figure Global Multiple Sclerosis Revenue Market Share by Application in 2018
Figure United States Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Sclerosis Market Share (2018-2019)
Table United States Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Sclerosis Market Share by Type (2014-2019)
Table United States Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Sclerosis Market Share by Application (2014-2019)
Figure Europe Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Sclerosis Market Share (2018-2019)
Table Europe Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Market Share by Type (2014-2019)
Table Europe Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Sclerosis Market Share by Application (2014-2019)
Figure China Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Sclerosis Market Share (2018-2019)
Table China Multiple Sclerosis Market Size by Type (2014-20189) (Million US$)
Table China Multiple Sclerosis Market Share by Type (2014-2019)
Table China Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table China Multiple Sclerosis Market Share by Application (2014-2019)
Figure Japan Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Sclerosis Market Share (2018-2019)
Table Japan Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Market Share by Type (2014-2019)
Table Japan Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Sclerosis Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Sclerosis Market Share (2018-2019)
Table Southeast Asia Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Market Share by Type (2014-2019)
Table Southeast Asia Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Sclerosis Market Share by Application (2014-2019)
Figure India Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Sclerosis Market Share (2018-2019)
Table India Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table India Multiple Sclerosis Market Share by Type (2014-2019)
Table India Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table India Multiple Sclerosis Market Share by Application (2014-2019)
Figure Central & South America Multiple Sclerosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Sclerosis Market Share (2018-2019)
Table Central & South America Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Market Share by Type (2014-2019)
Table Central & South America Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Sclerosis Market Share by Application (2014-2019)
Table Abbvie Company Details
Table Abbvie Revenue in Multiple Sclerosis Business (2014-2019) (Million US$)
Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Abbvie Recent Development
Table Acorda Therapeutics Company Details
Table Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Acorda Therapeutics Recent Development
Table Bayer HealthCare Company Details
Table Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Bayer HealthCare Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Bayer HealthCare Recent Development
Table Biogen Company Details
Table Biogen Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Biogen Recent Development
Table Genzyme (Sanofi) Company Details
Table Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Genzyme (Sanofi) Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Genzyme (Sanofi) Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Serono Company Details
Table Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Merck Serono Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Merck Serono Recent Development
Table Novartis Company Details
Table Novartis Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
Figure Teva Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
Table Teva Recent Development
Table Global Multiple Sclerosis Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Sclerosis Market Size Share by Regions (2019-2025)
Figure Global Multiple Sclerosis Market Size Share by Regions in 2025
Figure United States Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Sclerosis Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Market Size by Product (2019-2025)
Figure Global Multiple Sclerosis Market Size by Product in 2025
Table Global Multiple Sclerosis Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Sclerosis Market Size by Application (2019-2025)
Figure Global Multiple Sclerosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs